series-b
Stage
1
Investors
About
Nura Bio develops neuroprotective therapies focused on targeting axon degeneration and neuroimmune regulation pathways to treat neurological diseases.
Explore Nura Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.